Comparative Analysis of the Antioxidant, Antidiabetic, Antibacterial, Cytoprotective Potential and Metabolite Profile of Two Endophytic Penicillium spp.
Kumar Vishven NaveenKandasamy SaravanakumarAnbazhagan SathiyaseelanMyeong Hyeon WangPublished in: Antioxidants (Basel, Switzerland) (2023)
The current study assessed the metabolite abundance, alpha (α)-amylase and α-glucosidase inhibitory, antioxidant, and antibacterial activity of the ethyl acetate extract (EAE) of endophytic Penicillium lanosum (PL) and Penicillium radiatolobatum (PR). A higher extract yield was found in EAE-PR with a total phenolic content of 119.87 ± 3.74 mg of GAE/g DW and a total flavonoid content of 16.26 ± 1.95 mg of QE/g DW. The EAE-PR inhibited α-amylase and scavenged ABTS+ radicals with a half-maximal inhibitory concentration (IC 50 ) of 362.5 and 37.5 µg/mL, respectively. Compared with EAE-PL, EAE-PR exhibited higher antibacterial activity against Gram-positive and Gram-negative pathogens. Treatment with EAE-PR (1000 µg/mL) did not cause significant toxicity in the HEK-293 cell line compared to the control cells ( p < 0.05). EAE-PR treatments (250-1000 µg/mL) showed higher cytoprotective effects toward H 2 O 2 -stressed HEK-293 cells compared with ascorbic acid (AA). The UHPLC-Q-TOF-MS/MS analysis revealed the presence of thiophene A (C 13 H 8 S), limonene (C 10 H 16 ), and phenylacetic acid (C 8 H 8 O 2 ) in EAE-PR. Furthermore, these compounds demonstrated substantial interactions with diabetes (α-amylase and α-glucosidase), oxidative stress (NADPH-oxidase), and bacteria (D-alanine D-alanine ligase)-related enzymes/proteins evidenced in silico molecular docking analysis.
Keyphrases
- molecular docking
- oxidative stress
- gram negative
- induced apoptosis
- multidrug resistant
- anti inflammatory
- type diabetes
- molecular dynamics simulations
- ms ms
- silver nanoparticles
- mass spectrometry
- multiple sclerosis
- signaling pathway
- diabetic rats
- cell death
- microbial community
- antimicrobial resistance
- heat shock
- antibiotic resistance genes
- human health
- combination therapy